Alaunos Therapeutics, Inc. Financial Ratios — TCRT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-75.2	-100.39	-73.61	-54.33	-120.72	-127.12	-51.26	-52.94	-115.39	-62.61	-65.3	-47.22	-96.01	-84.93	-145.99
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	- -	- -	100	100	100	100	100
EBITDA Margin (%)	-10,664.47	-12,688.88	-7,121.88	-3,134.52	-2,764.15	-2,405.15	-831.49	-36,528.08	- -	- -	-18,646.23	-1,111.53	-523,560	-48,100	-84,360
Operating Margin (%)	-10,704.65	-12,771.12	-7,214.12	-3,168.17	-2,772.39	-2,409.37	-837.27	-36,921.92	- -	- -	-19,298.74	-1,205.95	-569,860	-48,120	-84,500
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	2,706.85	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-9,561.92	-12,016.5	-7,138.38	-2,314.71	-2,772.11	-2,409.23	-850.26	-36,381.51	- -	- -	-19,786.68	-1,291.24	-702,800	-46,790	-83,520
Profit Margin (%)	-9,561.92	-12,016.5	-7,138.38	-2,314.71	-2,772.11	-2,409.23	-850.26	-36,381.51	- -	- -	-19,786.68	-1,291.24	-702,800	-46,790	-83,520
Net Income to Common Margin (%)	-9,561.92	-12,016.5	-7,138.38	-2,314.71	-2,772.11	-2,513.04	-1,146.67	-48,023.97	- -	- -	-19,786.68	-1,291.24	-702,800	-46,790	-83,520
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	4.13	25.85	24.24	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	5	29	20	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	1	9	17	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	4	21	2	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.04	-0.06	-0.4	-0.6	- -	- -	- -
Net Debt/EBITDA	1.47	0.72	1.2	0.99	1.18	0.49	1.34	1.16	1.39	1.45	0.7	0.69	0.23	0.23	0.33
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.04	-0.06	-0.38	-0.55	- -	- -	- -
Net Debt/EBIT	1.47	0.72	1.18	0.98	1.17	0.49	1.33	1.15	1.38	1.43	0.68	0.63	0.21	0.23	0.33
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-62.42	-10.3	-13.63	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-65.21	-10.37	-13.73	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-64.6	-11.17	-14.83	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3	2	- -	- -
Common Equity/Total Assets	-173.46	-340.08	-474.86	-823.46	-320.42	-618.6	-674.49	-595.65	-626.82	-521.98	-888.25	-1,356.1	-11,082.72	-33,409.95	-31,173.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.66	3.22	35.77	5.68	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.23	-0.53	-2.55	-0.25	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.45	2.73	21.89	3.37	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.48	3.88	50.58	50.61	- -	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.35	-0.63	-3.61	-2.27	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.16	3.29	30.95	30.05	- -	- -	- -
Net Debt to Equity	-146.23	-151.32	-138.11	-126.48	-161.06	-168.78	-150.35	-72.14	-83.93	-92.81	-89.46	-57.82	-96.12	-52.88	-64.33
Net Debt/Capital (%)	35.83	20.54	16.68	10.31	22.22	13.21	11.1	9.83	10.47	13.16	5.84	2.48	0.66	0.12	0.15
EBITDA	-71	-102	-57	-43	-120	-165	-53	-53	-57	-79	-74	-32	-26	-5	-4
EBITDA-CapEx	-72	-103	-57	-43	-120	-166	-54	-54	-58	-89	-78	-33	-26	-5	-4
Operating Income (Loss)	-71	-102	-58	-43	-120	-165	-53	-54	-58	-80	-77	-35	-28	-5	-4

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7.84	3.89	8.75	3.95	7.76	5.13	3.4	6.51	6.37	6.26	4.74	1.62	3.1	1.58	1.7
Current Ratio	7.94	4.26	9.02	4.07	8.42	6.63	4.35	8.89	8.42	7.11	4.91	2.23	4.22	3.98	2.45
Quick Ratio	7.84	3.89	8.77	3.97	7.79	5.13	3.4	6.71	6.63	6.52	4.81	1.62	3.1	1.58	1.71
CFO/Avg Current Liab	-4.58	-4.89	-4.47	-3.94	- -	-3.44	-2.98	-3.26	-3.71	-3.69	-3.57	-1.45	-2.31	-3.75	-3.81
Common Equity/Total Assets	-173.46	-340.08	-474.86	-823.46	-320.42	-618.6	-674.49	-595.65	-626.82	-521.98	-888.25	-1,356.1	-11,082.72	-33,409.95	-31,173.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.66	3.22	35.77	5.68	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.23	-0.53	-2.55	-0.25	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.45	2.73	21.89	3.37	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.48	3.88	50.58	50.61	- -	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.35	-0.63	-3.61	-2.27	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.16	3.29	30.95	30.05	- -	- -	- -
CFO/Total Liabilities	-106.39	-225.5	-266.01	-321.6	-0.02	-100	-93.58	-521.31	-289.66	-254.94	-167	-110.8	-1,541	-718.35	-352.89
CFO/CapEx	-33.59	-50.57	-450.83	-189.9	-0.02	-105.85	-74.18	-107.75	-143.85	-5.83	-18.5	-135.33	-153.01	- -	-29.28
Altman's Z-Score	1.21	-2.3	1.76	13.2	3.44	-5.55	-4.44	7.71	24.22	5.97	-10.5	-16.98	-160.42	-469.95	-436.02

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	16.89	11.68	7.88	9.47	14.66	29.38	319.45	0.16	- -	- -	0.14	5.24	2	3.33	1.25
Days Sales Outstanding	21.62	31.25	46.31	38.55	24.9	12.42	1.14	2,353.75	- -	- -	2,648.54	69.64	182.5	109.5	292
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	291	327	373	513	1,042	698	567	268	793	528	234	141	17	3	6
- Cash & Cash Equivalents	105	73	68	43	141	81	71	62	80	115	76	39	6	1	1
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	125	144	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	5	29	20	- -	- -	- -
Enterprise Value	186	253	305	470	901	742	640	207	715	418	187	121	11	2	5
Total Capital	-188	-284	-341	-373	-493	-533	-568	-566	-682	-759	-813	-861	-916	-920	-925
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.35	-0.63	-3.61	-2.27	- -	- -	- -
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.16	0.16	- -	- -	- -
EV/Sales	279.41	316.81	380.99	342.26	208.1	108.13	100.17	1,415.29	- -	- -	469.86	41.55	2,181.81	196.74	981.64
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	2,242.51	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	291	327	373	513	1,042	698	567	269	793	528	234	141	17	3	6
Diluted Enterprise Value	186	253	305	470	901	742	640	207	715	418	187	121	11	2	5
EV per Share	423.53	484.01	531.96	697.01	1,078.2	853.43	701.01	215.98	638.88	299.11	130.83	83.87	6.82	1.23	2.52
TTM Sales	1	1	1	1	4	7	6	- -	- -	- -	- -	3	- -	- -	- -
TTM EBITDA	-71	-102	-57	-43	-120	-165	-53	-53	-57	-79	-74	-32	-26	-5	-4
TTM Operating Income	-71	-102	-58	-43	-120	-165	-53	-54	-58	-80	-77	-35	-28	-5	-4
TTM Cash Flow to Firm	-39	-79	-60	-37	- -	-58	-55	-49	-41	-57	-60	-26	-28	-5	-3
TTM Free Cash Flow to Firm	-38	-77	-59	-36	- -	-58	-54	-49	-41	-47	-57	-26	-28	-5	-3

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-7.73	-4.23	-6.28	-14.06	2,592.56	-12.07	-10.51	-5.48	-19.54	-11.18	-4.02	-4.86	-0.57	-0.62	-2.27
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	186	253	305	470	901	742	640	207	715	418	187	121	11	2	5
Low Price	532.5	504	223.5	346.5	730.5	667.5	585	234	271.5	269.25	160.56	60.8	6.6	1.63	1.31
EV/Sales	279.41	316.81	380.99	342.26	208.1	108.13	100.17	1,415.29	- -	- -	469.86	41.55	2,181.81	196.74	981.64
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-5.7	-4.13	-4.96	-11.85	-11.04	-4.81	-10.96	-7.1	-6.17	-7.87	-7.28	-6.36	-2.62	-3.18	-1.26
Price/Earnings High	-8.12	-5.17	-8.95	-17.76	-15.59	-7.37	-14.73	-10.74	-10.34	-13.39	-16.2	-23.08	-5.87	-11.24	-2.89
Price/Earnings Low	-3.67	-2.75	-2.24	-7.35	-5.09	-3.37	-7.29	-3.19	-2.58	-4.71	-2.91	-2.33	-0.3	-0.56	-0.61
Price/Book Value	-1.55	-1.15	-1.09	-1.38	-2.12	-1.06	-0.8	-0.47	-1.16	-0.69	-0.28	-0.16	-0.02	- -	-0.01
Price/Book Value Average	-1.94	-1.4	-0.83	-1.01	-2.69	-1.26	-1.13	-0.88	-1.06	-0.82	-0.68	-0.27	-0.1	-0.02	-0.01
Price/Book Value High	-2.76	-1.75	-1.5	-1.51	-3.8	-1.93	-1.51	-1.33	-1.78	-1.4	-1.51	-0.99	-0.23	-0.06	-0.01
Price/Book Value Low	-1.25	-0.93	-0.38	-0.63	-1.24	-0.88	-0.75	-0.4	-0.44	-0.49	-0.27	-0.1	-0.01	- -	- -
Price/Tangible Book Value	4.06	6.74	7.55	15.15	11.93	-9.02	-5.86	3.14	8.34	4.26	4.03	3.66	2.69	1.48	2.92
Price/Tangible Book Value Average	5.08	8.2	5.73	11.13	15.18	-10.73	-8.29	5.81	7.65	5.07	9.87	6.22	14.6	7.22	2.44
Price/Tangible Book Value High	7.23	10.26	10.36	16.68	21.43	-16.43	-11.15	8.8	12.82	8.64	21.97	22.58	32.7	25.5	5.61
Price/Tangible Book Value Low	3.27	5.45	2.59	6.9	6.99	-7.51	-5.52	2.62	3.2	3.04	3.95	2.28	1.67	1.27	1.19
Price/Sales	436.4	408.44	466.24	373.44	240.58	101.68	88.73	1,838.09	- -	- -	587.17	48.24	3,394.21	305.84	1,258.64
Price/Sales Average	545.5	496.82	353.95	274.29	306.11	120.83	125.65	3,407.4	- -	- -	1,439.6	82.11	18,416	1,488.86	1,051.08
Price/Sales High	776.71	621.5	639.2	411	432.24	185.11	168.9	5,155.5	- -	- -	3,205.21	297.98	41,248.73	5,260.11	2,415.96
Price/Sales Low	351.29	329.89	160.07	170.15	140.99	84.57	83.59	1,533.38	- -	- -	576.61	30.12	2,111.38	261	510.47
Price/Cash Flow	-7.5	-4.14	-6.27	-13.99	-104,220.74	-11.96	-10.37	-5.43	-19.4	-9.27	-3.8	-4.82	-0.56	-0.62	-2.19
Price/Cash Flow Average	-9.37	-5.04	-4.76	-10.28	-132,606.82	-14.21	-14.68	-10.06	-17.8	-11.03	-9.32	-8.21	-3.05	-3	-1.83
Price/Cash Flow High	-13.34	-6.31	-8.59	-15.4	-187,246.16	-21.77	-19.74	-15.22	-29.8	-18.79	-20.75	-29.79	-6.84	-10.58	-4.21
Price/Cash Flow Low	-6.03	-3.35	-2.15	-6.37	-61,077.62	-9.95	-9.77	-4.53	-7.44	-6.6	-3.73	-3.01	-0.35	-0.53	-0.89
Price/Free Cash Flow Average	-9.66	-5.14	-4.77	-10.33	3,298.68	-14.35	-14.88	-10.17	-17.92	-13.32	-9.85	-8.27	-3.07	-3	-1.9
Price/Free Cash Flow High	-13.75	-6.43	-8.61	-15.48	4,657.86	-21.98	-20.01	-15.38	-30.01	-22.68	-21.94	-30.01	-6.89	-10.58	-4.36
Price/Free Cash Flow Low	-6.22	-3.42	-2.16	-6.41	1,519.34	-10.04	-9.9	-4.58	-7.49	-7.97	-3.95	-3.03	-0.35	-0.53	-0.92
EV/Sales Average	388.51	405.19	268.69	243.12	273.63	127.29	137.08	2,984.6	- -	- -	1,322.29	75.42	17,203.6	1,379.76	774.08
EV/Sales High	619.72	529.86	553.95	379.83	399.76	191.56	180.33	4,732.7	- -	- -	3,087.9	291.29	40,036.33	5,151.01	2,138.96
EV/Sales Low	194.3	238.26	74.81	138.97	108.51	91.02	95.02	1,110.58	- -	- -	459.31	23.43	898.98	151.9	233.47
EV/EBITDA Average	-3.64	-3.19	-3.77	-7.76	-9.9	-5.29	-16.49	-8.17	-11.35	-6.55	-7.09	-6.79	-3.29	-2.87	-0.92
EV/EBITDA High	-5.81	-4.18	-7.78	-12.12	-14.46	-7.96	-21.69	-12.96	-19.92	-12.13	-16.56	-26.21	-7.65	-10.71	-2.54
EV/EBITDA Low	-1.82	-1.88	-1.05	-4.43	-3.93	-3.78	-11.43	-3.04	-3.96	-3.36	-2.46	-2.11	-0.17	-0.32	-0.28
EV/EBIT Average	-3.63	-3.17	-3.72	-7.67	-9.87	-5.28	-16.37	-8.08	-11.23	-6.46	-6.85	-6.25	-3.02	-2.87	-0.92
EV/EBIT High	-5.79	-4.15	-7.68	-11.99	-14.42	-7.95	-21.54	-12.82	-19.71	-11.96	-16	-24.15	-7.03	-10.7	-2.53
EV/EBIT Low	-1.82	-1.87	-1.04	-4.39	-3.91	-3.78	-11.35	-3.01	-3.92	-3.31	-2.38	-1.94	-0.16	-0.32	-0.28
Last Price	661.5	624	651	760.5	1,246.5	802.5	621	280.5	708	378	163.5	97.37	10.61	1.91	3.23
High Price	1,177.35	949.5	892.5	837	2,239.5	1,461	1,182	786.75	1,087.5	766.5	892.5	601.5	128.94	32.85	6.2
Enterprise Value Average	259	324	215	334	1,185	873	876	436	650	519	526	220	86	14	4
Enterprise Value High	413	424	443	522	1,732	1,314	1,152	691	1,140	961	1,229	851	200	52	11
Enterprise Value Low	130	191	60	191	470	625	607	162	227	266	183	68	4	2	1

Shares Outstanding	- -	1	1	1	1	1	1	1	1	1	1	2	2	2	2
Diluted Weighted Avg Shares	- -	1	1	1	1	1	1	1	1	1	1	1	2	2	2
Basic Weighted Avg Shares	- -	1	1	1	1	1	1	1	1	1	1	1	2	2	2
Revenue per Share	1.52	1.53	1.4	2.04	5.18	7.89	7	0.15	- -	- -	0.28	2.02	- -	0.01	- -
EBITDA per Share	-161.65	-193.86	-99.44	-63.83	-143.21	-189.83	-58.19	-55.74	-51.11	-56.69	-51.92	-22.44	-16.37	-3	-2.16
Operating Income per Share	-162.26	-195.11	-100.73	-64.52	-143.64	-190.17	-58.6	-56.34	-51.67	-57.5	-53.74	-24.34	-17.81	-3.01	-2.17
Basic EPS, GAAP	-144.94	-183.58	-99.67	-47.14	-143.63	-198.35	-80.25	-73.29	-105.21	-57.22	-55.1	-26.07	-21.97	-2.92	-2.14
Basic EPS from Cont Ops	-144.94	-183.58	-99.67	-47.14	-143.63	-190.15	-59.5	-55.52	-105.21	-57.22	-55.1	-26.07	-21.97	-2.92	-2.14
Diluted EPS, GAAP	-144.94	-183.58	-99.67	-47.14	-143.63	-198.35	-80.25	-73.18	-105.21	-57.22	-55.1	-26.07	-21.97	-2.92	-2.14
Diluted EPS from Cont Ops	-144.94	-183.58	-99.67	-47.14	-143.63	-190.15	-59.5	-55.44	-105.21	-57.22	-55.1	-26.07	-21.97	-2.92	-2.14
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-88.26	-150.55	-103.86	-54.36	-0.01	-67.1	-59.88	-51.69	-36.49	-40.79	-43	-20.19	-18.84	-3.1	-1.47
Free Cash Flow per Basic Share	-90.88	-153.52	-104.09	-54.65	-0.5	-67.73	-60.69	-52.17	-36.74	-47.79	-45.33	-20.34	-18.97	-3.1	-1.52
Cash & Equivalents per Share	237.97	139.99	119.04	63.49	168.3	93.24	77.71	64.52	71.22	82.33	53.21	26.98	3.79	0.68	0.71
Book Value per Share	-426.16	-541.67	-594.69	-552.52	-589.12	-756.8	-780.24	-591.78	-610.84	-546.58	-589.53	-608.35	-572.52	-574.83	-474.56
Tangible Book Value per Share	162.73	92.52	86.19	50.19	104.5	-88.92	-106.04	89.43	84.85	88.71	40.62	26.63	3.94	1.29	1.11

Alaunos Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)